Compare COFS & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | SIGA |
|---|---|---|
| Founded | 1898 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.5M | 401.0M |
| IPO Year | 1995 | 2016 |
| Metric | COFS | SIGA |
|---|---|---|
| Price | $28.56 | $5.24 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 64.4K | ★ 751.2K |
| Earning Date | 04-29-2026 | 03-10-2026 |
| Dividend Yield | 4.13% | ★ 11.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.01 | 0.32 |
| Revenue | ★ $227,624,000.00 | N/A |
| Revenue This Year | $22.13 | N/A |
| Revenue Next Year | $4.47 | $224.81 |
| P/E Ratio | ★ $13.99 | $16.72 |
| Revenue Growth | ★ 63.64 | N/A |
| 52 Week Low | $24.89 | $4.81 |
| 52 Week High | $33.58 | $9.62 |
| Indicator | COFS | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 41.52 |
| Support Level | $28.34 | $4.81 |
| Resistance Level | $30.76 | $6.98 |
| Average True Range (ATR) | 0.89 | 0.22 |
| MACD | 0.14 | 0.06 |
| Stochastic Oscillator | 85.34 | 59.86 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.